Pipeline Database
Search clinical-stage assets by therapeutic area, modality, target, indication, stage and territory — then inquire on any row that fits your brief.
| Code | Targets | Indications | Preclinical | IND | Ph I | Ph II | Ph III | NDA/BLA |
|---|---|---|---|---|---|---|---|---|
| UB642 | HBV preS1 | Hepatitis B chronic |  | |||||
| UB522 | immune modulator | Hepatitis B chronic | ||||||
| UB349 | ASK-1 | Nonalcoholic steatohepatitis; Hepatic fibrosis | | |||||
| UB340 | TL1A | Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Systemic sclerosis | | |||||
| UB100 | HBV | Chronic hepatitis B | ||||||
| UB063 | HBV Caspid | Chronic hepatitis B | | |||||
| UB049 | μ opioid receptor | Opioid-induced constipation | ||||||
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →